MoonLake Immunotherapeutics

MLTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001821586

SEC filings (opens in a new tab)

In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding MoonLake Immunotherapeutics changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of MLTX: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	43	83	+40
Shares	39.4M	56.1M	+16.6M (+42.2%)
Value	$843.2M	$2.86B	+$2.02B (+239.1%)

New holders (47)

Institutions that held MoonLake Immunotherapeutics at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to MLTX in Q2 2023
Institution	Shares	Value	% of portfolio
Avoro Capital Advisors LLC	1,725,000	$88.0M	1.19%
T. Rowe Price Investment Management, Inc.	1,148,809	$58.6M	0.04%
Pictet Asset Management SA	894,005	$45.6M	0.05%
Alliancebernstein L.P.	837,759	$42.7M	0.02%
Banque Pictet & Cie SA	640,000	$32.6M	0.29%
Wellington Management Group LLP	413,269	$21.1M	0.00%
Westfield Capital Management Co LP	410,119	$20.9M	0.13%
Artal Group S.A.	400,000	$20.4M	0.65%
Avidity Partners Management LP	400,000	$20.4M	0.71%
Paradigm Biocapital Advisors LP	369,615	$18.9M	1.53%
Finepoint Capital LP	302,000	$15.4M	5.33%
Integral Health Asset Management, LLC	300,000	$15.3M	2.01%
MPM Oncology Impact Management LP	295,111	$15.1M	3.03%
Franklin Resources Inc	200,000	$10.2M	0.00%
Lord, Abbett & Co. LLC	194,703	$9.93M	0.03%
Sectoral Asset Management Inc	184,590	$9.41M	1.57%
Nuveen Asset Management, LLC	140,000	$7.14M	0.00%
OrbiMed Advisors LLC	117,000	$5.97M	0.12%
Deep Track Capital, LP	108,450	$5.53M	0.26%
Goldman Sachs Group Inc	89,501	$4.56M	0.00%
Altium Capital Management LP	88,000	$4.49M	3.51%
Parkman Healthcare Partners LLC	80,000	$4.08M	0.71%
Hudson Bay Capital Management LP	60,000	$3.06M	0.03%
Marshall Wace, LLP	58,383	$2.98M	0.01%
Alyeska Investment Group, L.P.	57,347	$2.92M	0.02%
Monashee Investment Management LLC	50,000	$2.55M	0.61%
Woodline Partners LP	49,479	$2.52M	0.03%
Squarepoint Ops LLC	41,431	$2.11M	0.01%
Ergoteles LLC	38,617	$1.97M	0.09%
Voya Investment Management LLC	35,090	$1.79M	0.00%
TimesSquare Capital Management, LLC	30,000	$1.53M	0.02%
Victory Capital Management Inc	20,950	$1.07M	0.00%
EAM Investors, LLC	20,917	$1.07M	0.20%
Gilder Gagnon Howe & Co LLC	15,047	$767.4K	0.01%
Tudor Investment Corp Et Al	13,549	$691.0K	0.01%
ArrowMark Colorado Holdings LLC	10,000	$510.0K	0.01%
Shay Capital LLC	9,500	$484.5K	0.17%
Connor, Clark & Lunn Investment Management Ltd.	9,421	$480.5K	0.00%
Wedbush Securities Inc	6,890	$351.0K	0.02%
LPL Financial LLC	6,095	$310.8K	0.00%
Envestnet Asset Management Inc	5,098	$260.0K	0.00%
The PNC Financial Services Group, Inc.	4,327	$220.7K	0.00%
Virtus ETF Advisers LLC	4,053	$206.7K	0.12%
Tower Research Capital LLC (TRC)	912	$46.5K	0.00%
New York State Common Retirement Fund	165	$8.41K	0.00%
Private Trust Co NA	34	$1.73K	0.00%
Allianz Asset Management GmbH	4,400	$224	0.00%

Sold out (7)

Institutions that held MoonLake Immunotherapeutics at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of MLTX in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Great Point Partners LLC	278,334	$5.95M
Cubist Systematic Strategies, LLC	59,858	$1.28M
Point72 Asset Management, L.P.	29,748	$636.3K
Jane Street Group, LLC	26,034	$556.9K
Boulder Hill Capital Management LP	14,500	$310.2K
Ensign Peak Advisors, Inc	11,575	$247.6K
UBS Group AG	7,960	$170.3K